| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |